Hematology · Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma

Understanding CLL and SLL

At a Glance

CLL and SLL are two names for one slow-growing cancer of abnormal B cells; the name depends on whether cells are mainly in blood or lymph nodes. Many people are monitored without immediate treatment, but fever, rapid node growth, breathing trouble, or uncontrolled bleeding need prompt care.

Being diagnosed with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) can feel overwhelming, particularly because the word “leukemia” often brings to mind a rapid, aggressive illness. However, for the vast majority of people, these conditions are indolent, meaning they are slow-growing and may not require treatment for many years ^[1]^[2].

One Disease, Two Names

If you are confused about whether you have CLL or SLL, you are not alone. These are not two different diseases; they are biologically identical manifestations of the same underlying condition ^[3]^[4]. They both involve the same type of mature, abnormal B-cells (a type of white blood cell) ^[5].

The only difference is where those cells choose to accumulate:

CLL is the name used when the abnormal cells are found primarily in your blood and bone marrow ^[3].
SLL is the name used when the cells are found primarily in your lymph nodes or other lymphoid tissues, with very few of them circulating in the blood ^[3]^[6].

Doctors use a test called flow cytometry to identify the unique “fingerprint” of these cells to confirm the diagnosis ^[5]^[7]. To be officially called CLL, your blood must contain at least 5,000 (5 x 10^9/L) of these clonal B-cells per microliter ^[8].

If you have fewer than 5,000 abnormal cells, and this lower count persists for at least 3 months without enlarged lymph nodes, enlarged organs, or low blood counts, it is called Monoclonal B-cell Lymphocytosis (MBL). MBL acts as a precursor condition that doctors simply monitor ^[8].

Why “Watch and Wait” is Often Recommended

Because CLL and SLL are typically slow-moving, starting treatment immediately does not always help you live longer or better if you aren’t feeling sick. Instead, doctors often use an approach called active surveillance, or “watch and wait” ^[1]. This involves regular tests and exams to ensure the disease isn’t changing. Many people live for decades without ever needing aggressive therapy ^[9]^[2].

Understanding the Risks

While most cases remain slow-moving, it is important to be aware of how the disease can change.

Increased Infection Risk: CLL and SLL affect your immune system, making it harder for your body to fight off viruses and bacteria ^[10]. Even a simple infection can sometimes become serious more quickly than it would for someone else ^[11].
Richter Transformation: In about 2% to 10% of cases, the slow-growing CLL/SLL can transform into a fast-growing, aggressive form of lymphoma ^[12]^[13]. This is known as Richter syndrome or Richter transformation ^[14]. This change is a medical priority because aggressive lymphoma requires different, more intensive treatment, and is typically confirmed by a PET/CT scan to identify the best spot for a new biopsy ^[15]^[16]^[13].

Action Plan: When to Call vs. When to Seek Emergency Care

It is crucial to distinguish between everyday symptoms, signs the disease is slowly progressing, and true medical emergencies.

Seek EMERGENCY Care immediately if you experience:

Signs of Sepsis: Shaking chills, extreme weakness, confusion, or a sudden drop in blood pressure ^[11]^[10].
Sudden Weakness or Breathing Issues: A dramatic drop in energy or severe shortness of breath, which could indicate a sudden drop in your red blood cell count (anemia) or another complication ^[17].
Uncontrolled Bleeding: Bleeding that will not stop, or coughing/vomiting blood.

Call your oncology team the SAME DAY if you experience:

Fever: A temperature of 100.4°F (38°C) or higher, especially if you are actively receiving treatment or have low white blood cell counts (neutropenia). Do not wait days to report a fever.
Rapid Lymph Node Growth: A lymph node (in the neck, armpit, or groin) that grows noticeably larger or painful over just a few days ^[18]^[19].

Report at your next visit (or send a portal message) for routine disease progression signs (B-Symptoms):

Drenching night sweats (the kind that require changing your pajamas or sheets) ^[18].
Unintentional weight loss (losing more than 10% of your body weight within six months) ^[18].

Common questions in this guide

Are CLL and SLL actually different diseases?

Not usually. They are biologically the same condition involving abnormal mature B cells; CLL is the term used when the cells are mainly in the blood and bone marrow, while SLL is used when they are mainly in lymph nodes or other lymphoid tissues.

How is CLL or SLL confirmed?

Flow cytometry examines a blood sample for the characteristic pattern, or fingerprint, of the abnormal B cells. Doctors may also use other tests, such as a lymph node biopsy, depending on where the cells are found and what the evaluation shows.

What does the 5,000-cell threshold mean in CLL and MBL?

CLL is diagnosed when the blood contains at least 5,000 clonal abnormal B cells per microliter. If the count stays below that level for at least three months and there are no enlarged lymph nodes or organs or low blood counts, the condition may be called monoclonal B-cell lymphocytosis, which is usually monitored.

Why do doctors use watch and wait for many people with CLL or SLL?

These conditions are often slow-growing, and immediate treatment may not help a person live longer or feel better when there are no concerning symptoms. Active surveillance means regular exams and tests, and some people never need treatment while others may need it if the disease changes.

Which symptoms should lead me to call my oncology team the same day?

A temperature of 100.4°F (38°C) or higher needs a same-day call, particularly if you are receiving treatment or have low white blood cell counts. Also call promptly for a lymph node that becomes noticeably larger or painful over a few days; do not wait for a routine appointment.

What CLL or SLL symptoms require emergency care?

Seek emergency care for shaking chills with extreme weakness or confusion, severe shortness of breath or sudden weakness, or bleeding that will not stop, including coughing or vomiting blood. These symptoms can signal a serious infection, a major drop in red blood cells, or another urgent complication.

What is Richter transformation and how is it checked?

Richter transformation, also called Richter syndrome, is when CLL or SLL changes into a fast-growing aggressive lymphoma; it occurs in about 2% to 10% of cases. Doctors commonly use a PET/CT scan to find the best area for a new biopsy, which helps confirm the change.

Get notified when new evidence is published on chronic lymphocytic leukemia/small lymphocytic lymphoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Key takeaways

CLL and SLL are biologically the same disease; the name depends on whether abnormal B cells are mainly in the blood and bone marrow or in lymph nodes and other lymphoid tissues.
Flow cytometry identifies the characteristic pattern of abnormal B cells, while a blood count of at least 5,000 clonal B cells per microliter supports the CLL designation; a persistent lower count without enlarged nodes, organs, or low blood counts may be MBL.
Active surveillance, also called watch and wait, is often recommended because CLL and SLL are usually slow-growing and immediate treatment may not benefit people without concerning symptoms.
CLL and SLL can weaken immune defenses, so a fever of 100.4°F (38°C) or higher warrants a same-day call to the oncology team, especially during treatment or with low white blood cell counts.
Rapid lymph-node growth may signal Richter transformation, while signs of sepsis, severe breathing problems or weakness, and uncontrolled bleeding require emergency care.

References (19)

1
Transformation in Low-grade B-cell Neoplasms.
Montgomery ND, Mathews SP
Surgical pathology clinics 2016; (9(1)):79-92.
PMID: 26940269
2
Long-term follow-up and future direction on the management of chronic lymphocytic leukemia/small lymphocytic leukemia.
Hanna KS, Fijalka A, Watson I, et al.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2022; (28(8)):1869-1884 doi:10.1177/10781552221103820.
PMID: 35635742
3
Tonsillar Hypertrophy in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: A Mini-Review.
Al-Shibly R, Ali EA, Qasem NM, et al.
Cureus 2025; (17(11)):e96963 doi:10.7759/cureus.96963.
PMID: 41409907
4
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology.
Wierda WG, Byrd JC, Abramson JS, et al.
Journal of the National Comprehensive Cancer Network : JNCCN 2020; (18(2)):185-217.
PMID: 32023533
5
Extramedullary and extranodal manifestations in chronic lymphocytic leukemia - an update.
Robak T, Puła A, Braun M, Robak E
Annals of hematology 2024; (103(9)):3369-3383 doi:10.1007/s00277-024-05854-1.
PMID: 39052034
6
Stage IV Small Lymphocytic Lymphoma Presenting with Unilateral Vision Loss.
Le C, Jacob A, Iyengar D, et al.
Case reports in oncological medicine 2020; (2020()):3752409 doi:10.1155/2020/3752409.
PMID: 32047683
7
Plasmablastic Transformation of CLL/SLL: The Role of Early NGS Diagnosis and Targeted Multimodal Therapy.
Filipović J, Milošević S, Terzić T, et al.
Diagnostics (Basel, Switzerland) 2026; (16(5)) doi:10.3390/diagnostics16050702.
PMID: 41827978
8
Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification.
Strati P, Shanafelt TD
Blood 2015; (126(4)):454-62 doi:10.1182/blood-2015-02-585059.
PMID: 26065657
9
An unusual presentation of chronic lymphocytic leukemia.
Atwal D, Raval M, Firwana B, et al.
Avicenna journal of medicine 2017; (7(3)):133-136 doi:10.4103/ajm.AJM_171_16.
PMID: 28791248
10
Ibrutinib Treatment for First-Line and Relapsed/Refractory Chronic Lymphocytic Leukemia: Final Analysis of the Pivotal Phase Ib/II PCYC-1102 Study.
Byrd JC, Furman RR, Coutre SE, et al.
Clinical cancer research : an official journal of the American Association for Cancer Research 2020; (26(15)):3918-3927 doi:10.1158/1078-0432.CCR-19-2856.
PMID: 32209572
11
Severe Hypercalcemia in a Patient with Chronic Lymphocytic Leukemia following Treatment Disruption.
Al-Bitar A, Al Bidewi Y, Alsawaf K, et al.
Case reports in oncology 2025; (18(1)):1256-1261 doi:10.1159/000548015.
PMID: 41063871
12
Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapies.
Khan M, Siddiqi R, Thompson PA
Annals of hematology 2018; (97(1)):1-15 doi:10.1007/s00277-017-3149-9.
PMID: 29063177
13
Outcomes of Richter's transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database.
Elnair R, Ellithi M, Kallam A, et al.
Annals of hematology 2021; (100(10)):2513-2519 doi:10.1007/s00277-021-04603-y.
PMID: 34279675
14
Biology and treatment of Richter syndrome.
Rossi D, Spina V, Gaidano G
Blood 2018; (131(25)):2761-2772 doi:10.1182/blood-2018-01-791376.
PMID: 29692342
15
Richter transformation of CLL.
Jain N, Keating MJ
Expert review of hematology 2016; (9(8)):793-801 doi:10.1080/17474086.2016.1199948.
PMID: 27351634
16
An Approach to Diagnosis of Richter Transformation in Chronic Lymphocytic Leukemia.
Broadway-Duren J
Journal of the advanced practitioner in oncology 2022; (13(5)):535-538 doi:10.6004/jadpro.2022.13.5.7.
PMID: 35910501
17
"Accelerated" chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): unraveling the biological gray zone of CLL/SLL in the era of novel therapies.
Vadasz B, Zak T, Aldinger J, et al.
Virchows Archiv : an international journal of pathology 2025; (486(4)):739-750 doi:10.1007/s00428-024-03920-7.
PMID: 39243299
18
Life-Threatening Fungal Infection in Richter Transformation of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Case Report and Brief Review of Literature.
Baral B, Ahuja K, Chhabra N, et al.
Cureus 2021; (13(6)):e15924 doi:10.7759/cureus.15924.
PMID: 34277298
19
Ulcerated cutaneous Richter syndrome.
De Mello RB, Do Vale ECS
Dermatology online journal 2020; (26(9)).
PMID: 33054942

This page is for informational purposes only and does not constitute medical advice. It cannot replace guidance from your oncology team, especially if you develop fever, breathing problems, or other urgent symptoms.